Advertisement
Singapore markets open in 6 hours 36 minutes
  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     
  • S&P 500

    5,017.18
    -5.03 (-0.10%)
     
  • Dow

    37,787.77
    +34.46 (+0.09%)
     
  • Nasdaq

    15,640.18
    -43.19 (-0.28%)
     
  • Bitcoin USD

    62,888.41
    +1,069.73 (+1.73%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Gold

    2,396.40
    +8.00 (+0.33%)
     
  • Crude Oil

    82.71
    +0.02 (+0.02%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     
  • Jakarta Composite Index

    7,166.81
    +35.97 (+0.50%)
     
  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

A Look at Sage Therapeutics’ NMDA Receptor Portfolio

A Look at Sage Therapeutics’ NMDA Receptor Portfolio

As discussed earlier, Sage Therapeutics (SAGE) is focused on the development of products for the treatment of life-threatening central nervous system (or CNS) disorders. The products under development include SAGE-718 and SAGE-904.